NCT00411034View on ClinicalTrials.gov

A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1999

Conditions
Analgesics, OpioidPain
Interventions
DRUG

OROS Hydromorphone HCI

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY